Significados de pneumococcal conjugate em inglês

Effective interventions are available, including pneumococcal conjugate vaccine and case management.

Data on serotype distribution would help to guide appropriate pneumococcal conjugate vaccine formulation.

I am responsible for the area which manufactures the drug substance for Pfizer's pneumococcal conjugate vaccine.

Vaccination may alter colonisation dynamics, evidenced by the rise in non-vaccine serotypes following pneumococcal conjugate vaccination.

Antibiotic-use policies may affect pneumococcal conjugate-vaccine effectiveness.

Objective: We review the impact of pneumococcal conjugate vaccine on pneumococcal mastoiditis in children at Texas Children's Hospital.

We further show that immunization with PspA is more broadly protective than the pneumococcal conjugate vaccine (Prevnar).

Existing non-vaccine-serotypes in most GPSCs preclude the removal of these lineages by pneumococcal conjugate vaccines; leaving potential for serotype replacement.

Invasive pneumococcal disease (IPD) epidemiology and the potential impact of the pneumococcal conjugate vaccine in Fiji are documented.

In 2009, South Africa became the first African country to include the pneumococcal conjugate vaccine in its routine infant immunisation programme.

This study shows that in Cameroon, 13-valent pneumococcal conjugate vaccine coverage is less than what is estimated for other African countries.

Invasive pneumococcal disease in older children and adults declined markedly after introduction in 2000 of the pneumococcal conjugate vaccine for young children.

The genomes represented pneumococci from before and after pneumococcal conjugate vaccine (PCV) introductions and were from children younger than 3 years.

On the other hand, the administration of pneumococcal conjugate vaccine is considered per se a possible means of reducing the incidence of the disease.

Before the introduction of pneumococcal conjugate vaccine (from 1995 to December 1999), 0 of 12 cases were 19A.

The serotypes in the 7-valent pneumococcal conjugate vaccine covered 42% of all infections and 73% of those caused by non-susceptible strains.